Compare Citius Pharmaceuticals Inc (CTXR) vs Essex Property Trust, Inc. (ESS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Essex Property Trust, Inc. — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: Essex Property Trust, Inc. is far larger — about 907× Citius Pharmaceuticals Inc's market cap, and Essex Property Trust, Inc. pays a 3.93% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | ESS | |
|---|---|---|
Market Cap | $20.01M | $18.15B |
Sector | Health | Real Estate |
52-Week High | $1.82 | $298.33 |
52-Week Low | $0.48 | $239.61 |
Enterprise Value | $16.23M | $24.75B |
Dividend Yield | — | 3.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →
